Medical device firm St. Jude Medical has received CE mark approval for its new Infinity Deep Brain Stimulation (DBS) system and directional DBS lead.
The Infinity DBS system, which is available in two sizes, is claimed to be the only upgradeable DBS system available to patients combating movement disorders.
The new system includes features that will help to provide enhanced service for patients suffering from Parkinson’s disease, tremor and dystonia, a disorder that causes involuntary muscle contractions.
St. Jude Medical group president Dr Eric Fain said: "The Infinity DBS system, including our directional lead and wireless technology, represents a major step forward in our DBS product portfolio, demonstrating St. Jude Medical’s commitment to patient-centric solutions to help alleviate the debilitating effects of movement disorders."
DBS systems include a surgically-implanted neurostimulator, which generates the electrical pulses and thin wires called leads that carry the pulses to the brain to determine the irregular nerve signals responsible for many of the symptoms of movement disorders.
Through using Bluetooth wireless technology, the system will establish communication between the St. Jude Medical Infinity DBS platform and Apple digital devices, which are used as patient and physician controllers.
The Infinity DBS system is said to operate in conjunction with the firm’s newly-approved directional DBS lead, which allows physicians to provide therapy according to the patient’s specific needs and avoids stimulation to areas that may create side effects.
Earlier this month, St. Jude Medical also received CE mark approval for the 27mm and 29mm Portico transcatheter aortic valve replacement (TAVR) system.
Image: The St. Jude Medical Infinity DBS system is the upgradeable DBS system available to patients battling movement disorders. Photo: courtesy of St. Jude Medical, Inc.